STOCKHOLM, Oct. 30, 2024 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today published the preliminary global revenue for Leqembi during the third quarter 2024, in conjunction with their partner Biogen's quarterly report. In total, sales of JPY 10 billion...
Leqembi® revenue totaled JPY 10 billion in the third quarter 2024
Seaking AlphaSeeking Alpha / Seaking Alpha 3 hours ago 1 Views
Comments